Switching from abacavir/lamivudine to tenofovir DF/emtricitabine reduces biomarkers of inflammation: a randomized proof of concept study.
暂无分享,去创建一个
D. Duprez | J. Baker | F. Rhame | R. Prosser | O. Alozie | D. Duprez | K. HupplerHullsiek | Henry Wk